Novel drugs approved by the EMA, the FDA and the MHRA in 2025
Samir Hasan, MD, SkinSpirit Denver's Medical Director, is an NYC fellowship-trained, board-certified plastic surgeon specializing in face, breast and body aesthetics
Avoid combining in the same application with strong acids (high-concentration AHA or BHA) because pH extremes can destabilize the copper complex
The agency says it has only limited safety information for the proposed methods of administration and cannot determine whether the compound would harm humans
Glucagon-Like Peptide-1 and Its Class B G ProteinCoupled Receptors: A Long March to Therapeutic Successes
Whilst several peptidesincluding Melanotan II, PT-141 (bremelanotide), and BPC-157have been discussed for treating erectile dysfunction, none are licensed by the MHRA for this use in the UK